RoosterBio's Ready-to-Print Stem Cell Product to Simplify Intensive Cell Expansion Processes
FREDERICK, MD: In this era of increasing demand for scientific innovation in healthcare industry, generating human cells for rapid clinical translation and bio-printing process became a tough task. RoosterBio- a designer of biofabrication tools for elevating the development of a sustainable regenerative medicine industry has unveiled the availability of ‘RoosterRTP-hBM-50M’ Ready-to-Print (RTP) stem cell product for bio-printers and tissue engineers.
RoosterBio provides standardized stem cell product platforms to propel affordable and easy to access living cellular technologies. It works with tissue engineers, cell therapists, synthetic biologists and clinicians to advance research and therapies and curtail the complexity of incorporating stem cells into products. Its translation-friendly products are high volume, affordable, and well-characterized adult human mesenchymal stem cells (hMSCs) paired with highly engineered media systems. MSCs are the single most used cell type in all of regenerative medicine and they can modulate the immune system and inflammatory cascades, enabling tissues and organs to regenerate.
Advancements in bioprinting are pushing demands in regenerative medicine, so to cope up with demands RoosterBio provides the cellular bioink. Now with the commercial launch of 50 Mn late-passage (PDL 15-20) cryo preserved hBM-MSCs, bioprinters can minimize the time, labor and cost intensive cell expansion and bioprinting processes. The RTP cell is designed to simplify and standardize the most complex and labor intensive aspects of bioprinting.
RoosterBio’s RTP product makes living cellular biomaterials for printing available, allowing allows bioprinters and tissue engineers to thaw and use stem cells for same day experiments. Further, by leveraging thawing and using hMSCs, scientists can reduce time between experiments for rapid experimental turn-around and publication.